| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.08 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.089 | 0.08 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.32 | 0.08 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |